Detalhe da pesquisa
1.
T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters.
Front Immunol
; 14: 1111629, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36761759
2.
Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development.
AAPS J
; 25(4): 55, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37266912
3.
The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner.
Cell Syst
; 13(2): 143-157.e3, 2022 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637888
4.
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.
Front Genet
; 12: 684152, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249101
5.
Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction.
Front Immunol
; 11: 1304, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32655572